Clinical Research Directory
Browse clinical research sites, groups, and studies.
MIRABEGRON AND UAS OUTCOMES DURING RIRS
Sponsor: Ankara Training and Research Hospital
Summary
The aim of this study is to evaluate whether there is a difference in the passage rate of the ureteral access sheath between patients who used mirabegron (a beta-3 receptor agonist) for overactive bladder and those who underwent retrograde intrarenal surgery for kidney stones, and those who did not use mirabegron. Considering that beta-3 receptors in the smooth muscle of the ureter cause relaxation in the ureter, the hypothesis that the passage rate of the access sheath increases in those using mirabegron, thus facilitating access to kidney stones and improving surgical success, will be investigated.
Official title: THE EFFECT OF PREOPERATIVE MIRABEGRON ON URETERAL ACCESS SHEATH INSERTION SUCCESS AND URETERAL INJURY DURING RETROGRADE INTRARENAL SURGERY: A RETROSPECTIVE COMPARATIVE STUDY
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
131
Start Date
2018-01-01
Completion Date
2025-02-10
Last Updated
2026-05-14
Healthy Volunteers
No
Interventions
Retrograde intrarenal surgery
In our study, we evaluated the üreteral access sheath insertion rate in patients already using mirabegron for overactive bladder and scheduled for RIRS surgery for kidney stones. No additional intervention was performed beyond the routine surgical procedure.
Locations (1)
Ankara Training and Research Hospital
Ankara, Altındağ, Turkey (Türkiye)